Cyclophosphamide is widely used to treat severe manifestations of numerous autoimmune rheumatic diseases including systemic sclerosis. Based on recent data, immunological and inflammatory activation ...
Patients who underwent autologous stem cell transplantation (ASCT) for diffuse cutaneous systemic sclerosis (dcSSc), also known as scleroderma, did no better than others receiving conventional ...
Cyclophosphamide is well established as a potential treatment for severe manifestations of SSc. Recent data point towards limited efficacy in SSc-ILD with positive outcomes in lung function, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results